Truist raised the firm’s price target on Cimpress (CMPR) to $110 from $100 and keeps a Buy rating on the shares. The company’s better than expected results for Q3 mark the third beat in as many quarters this year, reflecting sustained demand for its higher-value offerings, good execution and benefits from cross-Cimpress fulfillment, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMPR: